| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1092852900002273 |
| P698 | PubMed publication ID | 15520608 |
| P2093 | author name string | Sanjay Gupta | |
| Subramoniam Madhusoodanan | |||
| Olivera Bogunovic | |||
| Ronald Brenner | |||
| Harsha Reddy | |||
| P2860 | cites work | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. | Q44662788 | ||
| Consensus development conference on antipsychotic drugs and obesity and diabetes | Q94355363 | ||
| Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study | Q33899442 | ||
| Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum | Q38348350 | ||
| Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. | Q44167467 | ||
| Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials | Q44428863 | ||
| Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder | Q44513113 | ||
| P433 | issue | 11 | |
| P921 | main subject | schizophrenia | Q41112 |
| schizoaffective disorder | Q834047 | ||
| P304 | page(s) | 862-867 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | C N S Spectrums | Q15750260 |
| P1476 | title | Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies | |
| P478 | volume | 9 |
| Q41682303 | Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital |
| Q33755676 | Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole |
| Q34121832 | Aripiprazole for late-life schizophrenia |
| Q35876413 | Aripiprazole: the evidence of its therapeutic impact in schizophrenia |
| Q37460501 | Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature |
| Q37316813 | Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole |
| Q37960898 | Management of schizophrenia in late life with antipsychotic medications: a qualitative review |
| Q38047222 | Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients |
| Q46748244 | Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole |
| Q36687060 | Treatment of psychosis: 30 years of progress. |
| Q26827756 | Use of atypical antipsychotics in the elderly: a clinical review |
| Q47285056 | Weight changes during treatment with olanzapine in older adult patients with dementia and behavioral disturbances. |
Search more.